Imaging of pelvic malignancies with in-line FDG PET-CT: Case examples and common pitfalls of FDG PET

Naveen Subhas, Pavni V. Patel, Harpreet K. Pannu, Heather A. Jacene, Elliot K. Fishman, Richard L. Wahl

Research output: Contribution to journalArticlepeer-review

Abstract

The role of 2-[fluorine 18]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) in combination with computed tomography (CT) in the evaluation of pelvic malignancies has been rapidly growing in recent years. FDG PET has proved to be valuable in the evaluation of a variety of pelvic malignancies, including colorectal cancer, uterine cervical cancer, ovarian cancer, endometrial cancer, and non-Hodgkin lymphoma. However, a number of pitfalls are commonly encountered at FDG PET, including normal physiologic activity in bowel, ovaries, endometrium, and blood vessels and focal retained activity in ureters, bladder diverticula, pelvic kidneys, and urinary diversions. The use of an in-line FDG PET-CT system, with special attention given to proper patient preparation and scanning protocol, often provides valuable information to help localize and define disease and avoid potential diagnostic pitfalls.

Original languageEnglish (US)
Pages (from-to)1031-1043
Number of pages13
JournalRadiographics
Volume25
Issue number4
DOIs
StatePublished - 2005

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Imaging of pelvic malignancies with in-line FDG PET-CT: Case examples and common pitfalls of FDG PET'. Together they form a unique fingerprint.

Cite this